Sheldon L. Koenig's Net Worth
$1.45 Million
Who is Sheldon L. Koenig?
Sheldon L. Koenig has an estimated net worth of $1.45 Million. This is based on reported shares across multiple companies, which include Esperion Therapeutics, Inc., and PORTOLA PHARMACEUTICALS INC.
SEC CIK
Sheldon L. Koenig's CIK is 0001766524
Past Insider Trading and Trends
2021 was Sheldon L. Koenig's most active year for acquiring shares with 5 total transactions. Sheldon L. Koenig's most active month to acquire stocks was the month of December. 2020 was Sheldon L. Koenig's most active year for disposing of shares, totalling 9 transactions. Sheldon L. Koenig's most active month to dispose stocks was the month of June. 2022 saw Sheldon L. Koenig paying a total of $49,950.08 for 215,606 shares, this is the most they've acquired in one year. In 2020 Sheldon L. Koenig cashed out on 338,431 shares for a total of $480,669.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.90% | -14.55K |
$1.80 | -$26,131.80 | 752.27K |
Sep 17
| |||
Form 4
| +145.13% | 454K |
—
|
—
| 766.82K |
Mar 14
| |||
Form 4
| +6.83% | 20K |
$1.26 | $25,192.00 | 312.82K |
May 9
| |||
Form 4
| -2.33% | -7.00K |
$1.78 | -$12,479.22 | 292.82K |
Mar 17
| |||
Form 4
| +53.90% | 105K |
—
|
—
| 299.81K |
Mar 14
| |||
Form 4
| -2.72% | -5.44K |
$5.06 | -$27,509.70 | 194.81K |
Mar 7
| |||
Form 4
| -1.68% | -3.39K |
$6.94 | -$23,547.57 | 198.26K |
Sep 19
| |||
Form 4
| +4.53% | 8.61K |
$5.80 | $49,950.08 | 198.77K |
Aug 5
| |||
Form 4
| -2.34% | -4.55K |
$4.99 | -$22,719.03 | 190.16K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| -0.29% | -571.00 |
$4.58 | -$2,615.18 | 194.72K |
Mar 17
| |||
Form 4
| +146.30% | 116K |
—
|
—
| 195.29K |
Mar 14
| |||
Form 4
| +53.40% | 26.7K |
—
|
—
| 76.7K |
Oct 29
| |||
Form 4
| +66.67% | 20K |
—
|
—
| 50K |
May 17
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PORTOLA PHARMACEUTICALS INC No price found
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.08K |
$13.18 | -$96,054.32 |
0
|
Jun 18 - Jul 2
| |||
Form 4
| -10.22% | -4.33K |
$9.68 | -$41,885.36 | 37.99K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
| +64.30% | 16.25K |
—
|
—
| 41.52K |
Jan 31
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||